Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy have?

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy has 83 citations in the OpenAlex counts ScholarIQ stores.

When was Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy published?

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy has 2018 year in the ScholarIQ index.

What is the open-access status of Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy has bronze oa status in the ScholarIQ index.

What is the DOI of Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?

The DOI for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is on the source record.

What is the PMID of Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?

The PMID for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is on the source record.

What is the OpenAlex record for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy?

The OpenAlex for Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy is on the source record.